Clear All
12393 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
50881-0022-08 50881-0022 Ruxolitinib JAKAFI XR 22.0 mg/1 Chemotherapy Enzyme Inhibitor JAK 1/2 Oral May 1, 2026 In Use
50881-0011-08 50881-0011 Ruxolitinib JAKAFI XR 11.0 mg/1 Chemotherapy Enzyme Inhibitor JAK 1/2 Oral May 1, 2026 In Use
83634-0208-10 83634-0208 Bortezomib Bortezomib 3.5 mg/1 Chemotherapy Proteasome Inhibitor 26S Intravenous, Subcutaneous May 1, 2026 In Use
81279-0117-60 81279-0117 Dexamethasone Dexamethasone 0.25 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 1, 2026 In Use
00404-9771-02 00404-9771 Metoclopramide Hydrochloride METOCLOPRAMIDE 5.0 mg/mL Ancillary Therapy Antiemetic Dopamine-2 Receptor Antagonist Intramuscular, Intravenous Apr 30, 2026 In Use
55513-0160-21 55513-0160 Blinatumomab Blincyto Immunotherapy Monoclonal Antibody CD3 (T cells) and CD19 (B cells) Intravenous Apr 30, 2026 In Use
67046-1058-03 67046-1058 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Apr 28, 2026 In Use
67046-1379-03 67046-1379 PREDNISONE PREDNISONE 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 27, 2026 In Use
00310-1350-99 00310-1350 Osimertinib Tagrisso 80.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral Apr 19, 2026 In Use
85776-0201-30 85776-0201 Dronabinol SYNDROS 5.0 mg/mL Ancillary Therapy Antiemetic CB1/CB2 Oral Apr 16, 2026 In Use
52536-0342-05 52536-0342 Lomustine Lomustine 100.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Apr 15, 2026 In Use
25021-0471-66 25021-0471 Fulvestrant Fulvestrant 50.0 mg/mL Hormonal Therapy Estrogen Receptor Antagonist Intramuscular Apr 15, 2026 In Use
52536-0340-05 52536-0340 Lomustine Lomustine 10.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Apr 15, 2026 In Use
52536-0341-05 52536-0341 Lomustine Lomustine 40.0 mg/1 Chemotherapy Alkylating Agent Nitrosourea Oral Apr 15, 2026 In Use
48433-0050-03 48433-0050 Imatinib Imatinib Mesylate 400.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Apr 10, 2026 In Use
48433-0049-03 48433-0049 Imatinib Imatinib Mesylate 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Apr 10, 2026 In Use
71335-9715-08 71335-9715 PREDNISONE Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2026 In Use
71335-9715-04 71335-9715 PREDNISONE Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2026 In Use
72189-0673-21 72189-0673 Prednisone D/P Prednisone D/P 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2026 In Use
71335-9715-05 71335-9715 PREDNISONE Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2026 In Use
68001-0705-27 68001-0705 Paclitaxel Paclitaxel 6.0 mg/mL Chemotherapy Antimitotic Agent Taxane Intravenous Apr 9, 2026 In Use
71335-9715-06 71335-9715 PREDNISONE Prednisone 50.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Apr 9, 2026 In Use
16729-0697-06 16729-0697 Lenalidomide Lenalidomide 25.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Apr 8, 2026 In Use
16729-0692-09 16729-0692 Lenalidomide Lenalidomide 2.5 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Apr 8, 2026 In Use
39822-2080-01 39822-2080 Eribulin mesylate ERIBULIN MESYLATE 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Apr 7, 2026 In Use

Found 12393 results — Export these results